Comparative characterization of CHCl3 metabolism and toxicokinetics in rodent strains differently susceptible to chloroform-induced carcinogenicity

Environmental Toxicology and Pharmacology

Volumn 8, Issue 2, 2000, Pages 103-110

  Vittozzi, Luciano ^a   Gemma, Simonetta ^a   Sbraccia, Maria ^a   Testai, Emanuela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

B6C3F1 mouse; Chloroform; In vivo metabolism; Osborne Mendel rat; Sprague Dawley rat; Toxicokinetics

Indexed keywords

CHLOROFORM;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; COVALENT BOND; DRUG DISTRIBUTION; DRUG ELIMINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION; TOXICOKINETICS; XENOBIOTIC METABOLISM;

EID: 0034040057     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(00)00031-4     Document Type: Article

References (35)

1. Ahmadizadeh M., Kuo C.H., Hook J.B. Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution. J. Tox. Environ. Health. 8:1981;105-111.
2. Andersen M.E., Brusick D., Cohen S., Dragan Y., Frederick C., Goodman J.I., Hard G., Meek B., O'Flaherty E.J. Letter to the Editor. Toxicol. Appl. Pharmacol. 153:1998;133-134.
3. Brennan R.J., Schiestl R.H. Chloroform and carbon tetrachloride induce intrachromosomal recombination and oxidative free radicals in Saccharomyces cerevisiae. Mutat. Res. 397:1998;271-278.
4. Chiu N., Orme-Zavaleta J., Chiu A., Chen C., DeAngelo A., Brattin W., Blancato J. Characterization of cancer risk associated with exposure to chloroform. Environ. Carcinog. Ecotoxicol. Rev. C14:1996;81-104.
5. Colacci A., Bartoli S., Bonora B., Guidotti L., Lattanzi G., Mazzullo M., Niero A., Perocco P., Silingardi P., Grilli S. Chloroform bioactivation leading to nucleic acids binding. Tumori. 77:1991;285-290.
6. Corley R.A., Mendrala A.L., Smith F.A., Staats D.A., Gargas M.L., Conolly R.B., Andersen M.E., Reitz R.H. Development of physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103:1990;512-527.
7. 3 metabolites to microsomal phospholipids. Chem. Biol. Interact. 85:1992;229-242.
8. De Curtis V., Gemma S., Sbraccia M., Testai E., Vittozzi L. The contribution of electrophilic and radicalic intermediates to phospholipid adducts formed by halomethanes in vivo. J. Biochem. Toxicol. 9(6):1994;305-331.
9. Folch J., Lees M., Sloane-Stanley G.M. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
10. Gemma S., Ade P., Sbraccia M., Testai E., Vittozzi L. In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains. Environ. Toxicol. Pharmacol. 2:1996;233-242.
11. 3 bioactivation, toxicokinetics, toxicity and induced compensatory cell proliferation in B6C3F1 male mice. Toxicol. Appl. Pharmacol. 141:1996;394-402.
12. Golden R.J., Holm S.E., Robinson D.E., Julkunen P.H., Reese E.A. Chloroform mode of action: Implications for cancer risk assessment. Reg. Toxicol. Pharmacol. 26:1997;142-155.
13. Larson J.L., Wolf D.C., Butterworth B.E. Induced cytolethality and regenerative cell proliferation in the livers and kidneys of male B6C3F1 mice given chloroform by gavage. Fund. Appl. Toxicol. 23:1994;537-543.
14. Mansuy D., Beaune P., Cresteil T.H., Lange M., Leroux J.P. Evidence for phosgene formation during liver microsomal oxidation of chloroform. Biochem. Biophys. Res. Commun. 79:1977;513-517.
15. Melnick R.L., Kohn M.C., Dunnick J.K., Leininger J.R. Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol. Appl. Pharmacol. 148:1998;137-147.
16. Melnick R.L., Kohn M.C. Letter to the Editor (reply). Toxicol. Appl. Pharmacol. 153:1998;135-136.
17. 14C-trihalomethanes in mice and rats. Bull. Environ. Contam. Toxicol. 37:1986;752-758.
18. NCI, 1976. Report on carcinogenesis bioassay of chloroform. Natl. Tech. Inf. Serv. PB-264018/AS.
19. Palmer A.K., Street A.E., Roe F.J.C., Worden A.N., Van Abbe N.J. Safety evaluation of toothpaste containing chloroform. III. Long term studies in rats. J. Environ. Pathol. Toxicol. 2:1979;821-833.
20. Pegram R.A., Andersen M.E., Warren S.H., Ross T.M., Claxton L.D. Glutathione-S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: contrasting results with bromodichloromethane and chloroform. Toxicol. Appl. Pharmacol. 144:1997;183-188.
21. Pereira M.A. Route of administration determines whether chloroform enhances or inhibits cell proliferation in the liver of B6C3F1 mice. Fund. Appl. Toxicol. 23:1994;87-92.
22. Pohl L.R., Bhooshan B., Whittaker N.F., Krishna G. Phosgene: a metabolite of chloroform. Biochem. Biophys. Res. Commun. 79:1977;684-691.
23. Pohl L.R., George J.W., Martin J.L., Krishna G. Deuterium isotope effect in in vivo bioactivation of chloroform to phosgene. Biochem. Pharmacol. 28:1979;561-563.
24. Pohl L.R., Martin J.L., George J.W. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 29:1980;3271-3276.
25. Reynolds E.S., Treinen R.J., Farrish H.H., Moslen Treinen M. Metabolism of (14C)carbon tetrachloride to exhaled, excreted and bound metabolites. Biochem. Pharmacol. 33(21):1984;3363-3374.
26. Robbiano L., Meretto E., Migliazzi Morando A., Pastore P., Brambilla G. Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics. Mutat. Res. 413:1998;1-6.
27. Smith J.H., Hook J.B. Mechanism of chloroform nephrotoxicity III. Renal and hepatic metabolism of chloroform in mice. Toxicol. Appl. Pharmacol. 73:1984;511-524.
28. Smith J.H., Maita K., Sleight S.D., Hook J.B. Mechanism of chloroform nephrotoxicity I. Time course of chloroform toxicity in male and female mice. Toxicol. Appl. Pharmacol. 70:1983;467-479.
29. Testai E., Vittozzi L. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem. Biol. Interact. 59:1986;157-171.
30. Testai E., Di Marzio S., Vittozzi L. Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol. Appl. Pharmacol. 104:1990;496-503.
31. Testai E., Keizer J., Pacifici G.M., Vittozzi L. Chloroform bioactivation by microsomes from colonic and ileal mucosa of rat and man. Toxicol. Lett. 57:1991;19-27.
32. 3 carcinogenicity. Toxicol. Appl. Pharmacol. 114:1992;197-203.
33. Testai E., Di Marzio S., Di Domenico A., Piccardi A., Vittozzi L. An in vitro investigation of the reductive metabolites of chloroform. Arch. Toxicol. 70:1995;83-88.
34. Tomasi A., Albano E., Biasi F., Slater T.F., Vannini V., Dianzani M.U. Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocites and in the rat in vivo as detected by the ESR-spin trapping technique. Chem. Biol. Interact. 55:1985;303-316.
35. Withey J.R., Collins B.T. Chlorinated aliphatic hydrocarbons used in the foods industry: the comparative pharmacokinetics of methylene chloride, chloroform and trichloroethylene after i.v. administration in the rat. J. Environm. Pathol. Toxicol. 3:1980;313-332.